PP3252 - Neuropharmacology
Credit points: | 03 |
Year: | 2005 |
Student Contribution Band: | Band 2 |
Administered by: |
The pharmacology of the peripheral and central nervous systems. It examines neural communication as a target for drug intervention, and how drugs may be used to relieve pain, produce anaesthesia, regulate autonomic function, as well as control the symptoms of various neurological disorders. The subject also contains an introduction to behavioural pharmacology and the mechanisms of drug addiction.
Learning Outcomes
- approaches to studying behavioural pharmacology and its implications to therapeutic drug development as well as the understanding of addictive and other behaviour patterns;
- current knowledge of the neurochemical basis of neurological disease and its treatment, e.g. the use of neuroleptics in the treatment of schizophrenia;
- normal neuronal function and the targets at which neuronal function may be modified by drugs;
- the control of autonomic (vegetative) function and its modulation by drug treatments, e.g. the management of high blood pressure;
- the neurobiology of pain and current strategies and future developments in the control of pain.
Prerequisites: | BC2024 and PP2101 and PP2201 |
Availabilities | |
, , Study Period 2 | |
Census Date 31-Aug-2005 | |
Coordinator: | Anna-Marie Babey |
Lecturers: | jc132544, jc144749, Professor Alan Nimmo. |
Contact hours: |
|
Assessment: | (70%); (30%). |
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.